Oluseun Olufade
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Oluseun Olufade has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Aaron Chang
Department of Physical Medicine and Rehabilitation, Emory University School of Medicine, 1441 Clifton Road NE, Atlanta, GA 30322, USA
1 shared publication Amrish Patel
Sports and Spine Institute, Marietta, GA
1 shared publicationAnna L. Waterbrook
Emergency and Sports Medicine, The University of Arizona Tucson, Arizona
1 shared publication- Benjamin Sirutis
Department of Physical Medicine & Rehabilitation, Emory University, Atlanta, GA30307, USA
1 shared publication - Chase Demarest
Regenexx Cayman, George Town, Grand Cayman KY1-1208, Cayman Islands
1 shared publication - Chirstopher J. Williams
Department of Physical Medicine and Rehabilitation, Emory University School of Medicine, Atlanta, GA 30307, USA
1 shared publication
Latest Publications
- Open Access
- 25 September 2026
- Published by MDPI AG in Biomedicines
- Vol. 14 (10) , 2174
Review Article of Platelet-Rich Plasma and Facet-Mediated Mechanical Low Back Pain
Introduction and Aim: Facet-mediated mechanical low back pain is a common contributor to chronic disability worldwide. While platelet-rich plasma (PRP) has demonstrated efficacy in discogenic low back pain, its role in facet joint-mediated pain remains less clearly defined. This narrative review aimed to evaluate the existing clinical evidence on the use of PRP for lumbar facet-mediated mechanical low back pain. Materials and Methods: A comprehensive PubMed search was conducted in October 2024 for studies published between 2014 and 2024, with one additional eligible study published in 2025 included subsequently. Eligibility included clinical studies evaluating intra-articular or periarticular PRP directed at lumbar facet-related pain. Because the original search was limited to a single database and the review was not conducted under a prospectively registered systematic-review protocol, the present article is explicitly framed as a structured narrative review rather than a systematic review. Results: Six studies were identified: one randomized controlled trial, one prospective controlled nonrandomized study, two prospective case series, one retrospective observational study, and one small case series. The most direct comparative evidence suggests that PRP may provide longer-lasting benefit than local anesthetic/corticosteroid injection, while the 2025 prospective nonrandomized study suggests longer-term improvement compared with local anesthetic. However, several studies used multiple spinal injection targets, and the evidence is further limited by small samples, heterogeneous PRP formulations and treatment protocols, variable diagnostic criteria, and incomplete safety reporting. Conclusion: Overall, current evidence supports PRP as a promising but not established treatment for lumbar facet-mediated low back pain. Nevertheless, the overall quality of evidence remains limited, underscoring the need for larger, standardized, and long-term controlled studies.
- 25 September 2026
- Published by MDPI AG in Biomedicines
- Vol. 14 (10) , 2174
Open AccessReview Article of Platelet-Rich Plasma and Facet-Mediated Mechanical Low Back Pain
Introduction and Aim: Facet-mediated mechanical low back pain is a common contributor to chronic disability worldwide. While platelet-rich plasma (PRP) has demonstrated efficacy in discogenic low back pain, its role in facet joint-mediated pain remains less clearly defined. This narrative review aimed to evaluate the existing clinical evidence on the use of PRP for lumbar facet-mediated mechanical low back pain. Materials and Methods: A comprehensive PubMed search was conducted in October 2024 for studies published between 2014 and 2024, with one additional eligible study published in 2025 included subsequently. Eligibility included clinical studies evaluating intra-articular or periarticular PRP directed at lumbar facet-related pain. Because the original search was limited to a single database and the review was not conducted under a prospectively registered systematic-review protocol, the present article is explicitly framed as a structured narrative review rather than a systematic review. Results: Six studies were identified: one randomized controlled trial, one prospective controlled nonrandomized study, two prospective case series, one retrospective observational study, and one small case series. The most direct comparative evidence suggests that PRP may provide longer-lasting benefit than local anesthetic/corticosteroid injection, while the 2025 prospective nonrandomized study suggests longer-term improvement compared with local anesthetic. However, several studies used multiple spinal injection targets, and the evidence is further limited by small samples, heterogeneous PRP formulations and treatment protocols, variable diagnostic criteria, and incomplete safety reporting. Conclusion: Overall, current evidence supports PRP as a promising but not established treatment for lumbar facet-mediated low back pain. Nevertheless, the overall quality of evidence remains limited, underscoring the need for larger, standardized, and long-term controlled studies.
- Open Access
- 26 September 2025
- Published by MDPI AG in Biomedicines
- Vol. 13 (10) , 2365
Long-Term Effectiveness of Intradiscal Culture-Expanded Mesenchymal Stem Cells (MSCs) with Platelet Products for Discogenic Low Back Pain
Background/Objectives: Low back pain (LBP) remains one of the leading causes of disability globally and contributes significantly to healthcare expenditures. Discogenic LBP, a subtype stemming from intervertebral disc degeneration, often provesrefractory to conventional treatment modalities. Regenerative orthobiologic therapies, including platelet-rich plasma (PRP), platelet lysate (PL), and mesenchymal stem cells (MSCs), have emerged as promising alternatives, though long-term outcomes and safety profiles are not yet well understood. Methods: This case series reports 13 patients treated between 2015 and 2016 at an outpatient interventional pain center who received intradiscal culture-expanded MSC injections with or without additional injections to other surrounding vertebral structures. There was no control group. Inclusion required patients to have discogenic LBP with or without radiculopathy and at least six years of completed follow-up data. Outcomes were assessed using Numeric Rating Scale (NRS), Functional Rating Index (FRI), and modified Single Assessment Numeric Evaluation (SANE) scores at multiple time points up to 10 years post treatment. Results: Thirteen patients met the inclusion criteria. Significant reductions in NRS and FRI scores were observed at 6 months, 3 years, and 6 years (p < 0.01). At 6 years, the average NRS score decreased by 2.50 points, FRI by 24.14 points, and SANE showed a 60% improvement. At 10 years, among the seven patients who responded, average SANE improvement was 78.1%. No adverse events were reported. Conclusions: This study presents the longest known follow-up data for intradiscal MSC therapy for discogenic LBP, demonstrating sustained improvements in pain and function. These findings support further investigation into combination orthobiologic therapies as a viable long-term treatment option for chronic LBP.
- 26 September 2025
- Published by MDPI AG in Biomedicines
- Vol. 13 (10) , 2365
Open AccessLong-Term Effectiveness of Intradiscal Culture-Expanded Mesenchymal Stem Cells (MSCs) with Platelet Products for Discogenic Low Back Pain
Background/Objectives: Low back pain (LBP) remains one of the leading causes of disability globally and contributes significantly to healthcare expenditures. Discogenic LBP, a subtype stemming from intervertebral disc degeneration, often provesrefractory to conventional treatment modalities. Regenerative orthobiologic therapies, including platelet-rich plasma (PRP), platelet lysate (PL), and mesenchymal stem cells (MSCs), have emerged as promising alternatives, though long-term outcomes and safety profiles are not yet well understood. Methods: This case series reports 13 patients treated between 2015 and 2016 at an outpatient interventional pain center who received intradiscal culture-expanded MSC injections with or without additional injections to other surrounding vertebral structures. There was no control group. Inclusion required patients to have discogenic LBP with or without radiculopathy and at least six years of completed follow-up data. Outcomes were assessed using Numeric Rating Scale (NRS), Functional Rating Index (FRI), and modified Single Assessment Numeric Evaluation (SANE) scores at multiple time points up to 10 years post treatment. Results: Thirteen patients met the inclusion criteria. Significant reductions in NRS and FRI scores were observed at 6 months, 3 years, and 6 years (p < 0.01). At 6 years, the average NRS score decreased by 2.50 points, FRI by 24.14 points, and SANE showed a 60% improvement. At 10 years, among the seven patients who responded, average SANE improvement was 78.1%. No adverse events were reported. Conclusions: This study presents the longest known follow-up data for intradiscal MSC therapy for discogenic LBP, demonstrating sustained improvements in pain and function. These findings support further investigation into combination orthobiologic therapies as a viable long-term treatment option for chronic LBP.
- 19 May 2022
- Published by Taylor & Francis in Regenerative Medicine
- Vol. 17 (7) , 431-443
Amniotic Dehydrated Cell and Protein Concentrate Versus Corticosteroid in Knee Osteoarthritis: Preliminary Findings
Objectives: The purpose is to report preliminary data on clinical response to dehydrated cell and protein concentrate (dCPC) versus corticosteroid (CSI). Design: A single-site prospective, randomiz... Plain language summary The purpose of this study was to discuss preliminary data from a clinical trial comparing a single injection of an amniotic-derived tissue product (dehydrated cell and protei... Tweetable abstract In a preliminary analysis of an RCT comparing amniotic dCPC to corticosteroid injection for knee osteoarthritis, researchers found that dCPC may be a viable treatment option. Thi...
- 19 May 2022
- Published by Taylor & Francis in Regenerative Medicine
- Vol. 17 (7) , 431-443
Amniotic Dehydrated Cell and Protein Concentrate Versus Corticosteroid in Knee Osteoarthritis: Preliminary Findings
Objectives: The purpose is to report preliminary data on clinical response to dehydrated cell and protein concentrate (dCPC) versus corticosteroid (CSI). Design: A single-site prospective, randomiz... Plain language summary The purpose of this study was to discuss preliminary data from a clinical trial comparing a single injection of an amniotic-derived tissue product (dehydrated cell and protei... Tweetable abstract In a preliminary analysis of an RCT comparing amniotic dCPC to corticosteroid injection for knee osteoarthritis, researchers found that dCPC may be a viable treatment option. Thi...
- 11 May 2022
- Published by Springer Nature
- p. 215-226
Shoulder Dislocations and Fractures
- 1 July 2021
- Published by Wolters Kluwer Health in Optometry and Vision Science
- Vol. 20 (7) , 366-373
Suggested Curricular Guidelines for Musculoskeletal and Sports Medicine in Physical Medicine and Rehabilitation Residency Training
A sports medicine physician manages musculoskeletal (MSK) injuries and sport-related medical and MSK conditions of patients of all ages and abilities. Physical medicine and rehabilitation physicians (physiatrists) must be adequately trained to provide this care for all patients including, but not limited to, athletes participating in organized sports, the weekend warrior as well as athletes with disabilities. Accreditation Council of Graduate Medical Education core requirements and basic guidelines help physiatry residency training programs develop and implement residency curriculums. The goal of this article is to provide suggested curricular guidelines to optimize physiatrist training in MSK and sports medicine.
- 1 July 2021
- Published by Wolters Kluwer Health in Optometry and Vision Science
- Vol. 20 (7) , 366-373
Suggested Curricular Guidelines for Musculoskeletal and Sports Medicine in Physical Medicine and Rehabilitation Residency Training
A sports medicine physician manages musculoskeletal (MSK) injuries and sport-related medical and MSK conditions of patients of all ages and abilities. Physical medicine and rehabilitation physicians (physiatrists) must be adequately trained to provide this care for all patients including, but not limited to, athletes participating in organized sports, the weekend warrior as well as athletes with disabilities. Accreditation Council of Graduate Medical Education core requirements and basic guidelines help physiatry residency training programs develop and implement residency curriculums. The goal of this article is to provide suggested curricular guidelines to optimize physiatrist training in MSK and sports medicine.